ImmunoGen Inc. (IMGN)
NASDAQ: IMGN
· Real-Time Price · USD
31.23
0.00 (0.00%)
At close: Feb 09, 2024, 9:58 PM
ImmunoGen Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 30.75M | -4.25M | -41.01M | -59.01M | -77.75M | -62.02M | -24.14M | -37.17M | -37.34M | -30.74M | -34.05M |
Depreciation & Amortization | 423K | 427K | 448K | 428K | 424K | 458K | 473K | 462K | 462K | 542K | 551K |
Stock-Based Compensation | 7.8M | 7.43M | 7.07M | 10.75M | 5.48M | 4.97M | 4.41M | 6.43M | 3.48M | 3.74M | 3.82M |
Other Working Capital | -6.5M | -2.3M | -10.49M | -5.83M | 6.4M | -6.59M | -21.99M | -13.19M | -2.28M | -87K | -1.64M |
Other Non-Cash Items | -28.4M | -1.8M | -1.3M | -2.84M | -2.57M | -2.15M | -1.11M | -1.97M | -563K | -12.62M | -10.9M |
Deferred Income Tax | 61.4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -69.2M | -68.55M | -38.92M | -9.53M | 10.21M | -5.25M | -21.02M | -13.63M | -1.08M | -4.8M | -4.04M |
Operating Cash Flow | 2.77M | -66.74M | -73.72M | -60.2M | -64.21M | -63.99M | -41.4M | -45.87M | -35.04M | -43.88M | -44.62M |
Capital Expenditures | -1.35M | -78K | -209K | -248K | -602K | -207K | -307K | -369K | -125K | -47K | -893K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -1.35M | -78K | -209K | -248K | -602K | -207K | -307K | -369K | -125K | -47K | -893K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 32.13M | 437.56M | 39K | 26.07M | 449K | 411K | 620K | 279.23M | 41.39M | 344K | 34.78M |
Financial Cash Flow | 32.13M | 437.56M | 39K | 26.07M | 449K | 411K | 620K | 279.23M | 41.39M | 344K | 34.78M |
Net Cash Flow | 33.55M | 370.74M | -73.89M | -34.37M | -64.36M | -63.79M | -41.09M | 232.99M | 6.22M | -43.58M | -10.74M |
Free Cash Flow | 1.42M | -66.82M | -73.93M | -60.45M | -64.81M | -64.2M | -41.71M | -46.24M | -35.17M | -43.93M | -45.51M |